Showing results (1-10 of 82) with videos related to
Sort By:
Pageof 9
Current Opinion in Pharmacology|December 27, 2005
Glutamate- and GABA-based CNS therapeuticsAlan C Foster, John A KempCurrent Topics in Medicinal Chemistry|June 23, 2007
Melanocortin-4 receptor antagonists as potential therapeutics in the treatment of cachexiaAlan C Foster, Chen ChenPharmacology Research & Perspectives|May 23, 2022
Hearing loss: The final frontier of pharmacologyAlan C Foster, Bonnie E Jacques, Fabrice PiuNature Neuroscience|October 31, 2002
NMDA receptor pathways as drug targetsJohn A Kemp, Ruth M McKernanBrain Research|March 7, 2002
Ischemic preconditioning reduces infarct volume after subdural hematoma in the ratKenneth B Mackay, Theodore H Stiefel, Alan C FosterPsychopharmacology|February 26, 2005
Ionotropic and metabotropic glutamate receptor structure and pharmacologyJames N C Kew, John A KempThe Journal of Pharmacology and Experimental Therapeutics|June 18, 2002
Pharmacological evidence supporting a role for central corticotropin-releasing factor(2) receptors in behavioral, but not endocrine, response to environmental stressMary Ann Pelleymounter, Margaret Joppa, Nicholas Ling, et al.Idrugs : the Investigational Drugs Journal|April 1, 2005
MC4 receptor antagonists: a potential treatment for cachexiaAlan C Foster, Chen Chen, Stacy Markison, et al.Peptides|May 29, 2004
Behavioral and neuroendocrine effects of the selective CRF2 receptor agonists urocortin II and urocortin IIIMary Ann Pelleymounter, Margaret Joppa, Nick Ling, et al.Hearing Research|October 14, 2023
The efficacy of a TrkB monoclonal antibody agonist in preserving the auditory nerve in deafened guinea pigsHenk A Vink, Dyan Ramekers, Alan C Foster, et al.Pageof 9